Quick Takeaways
- Novo Holdings A/S filed SCHEDULE 13G/A for Zenas BioPharma, Inc. Common Stock, par value $0.0001 (ZBIO).
- Disclosed ownership: 4.7%.
- Date of event: 30 Sep 2025.
Novo Holdings A/S - 30 Sep 2025 SCHEDULE 13G/A Report for Zenas BioPharma, Inc. Common Stock, par value $0.0001 (ZBIO)
- Filing Manager
- Novo Holdings A/S
- Reporting Manager
- Novo Holdings A/S
- Symbol
- ZBIO
- Shares outstanding
- 42,553,191 shares
- Disclosed Ownership
- 2,000,000 shares
- Ownership
- 4.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 18:29:15 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 01 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Novo Holdings A/S disclosed 4.7% ownership in Zenas BioPharma, Inc. Common Stock, par value $0.0001 (ZBIO) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 01 Apr 2025.
- Current filing was accepted on 14 Nov 2025, 18:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Novo Holdings A/S | 4.7% | 2,000,000 | 2,000,000 | 0 | Barbara Fiorini | Barbara Fiorini, General Counsel, Finance & Operations |